Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Advanced BioHealing gets $25.5mm in Series C

Executive Summary

Advanced BioHealing (cell-based and tissue engineered products for wound healing) raised $25.5mm through its Series C round that was led by Safeguard Scientifics. Channel Medical Partners, Red Abbey Venture Partners, Canaan Partners, and Wheatley Partners also participated. ABH will put the funds towards the recent launch of its diabetic foot ulcer product Dermagraft, which the company bought from Smith & Nephew last year.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Biomaterials
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies